Lyttkens K, Prytz H, Forsberg L, Hägerstrand I
Dept. of Diagnostic Radiology, University Hospital, Lund, Sweden.
Scand J Gastroenterol. 1995 Oct;30(10):1036-40. doi: 10.3109/00365529509096350.
The aim of this study was to investigate whether changes in lymph node size in the hepatoduodenal ligament reflect changes in biochemical and histologic markers of cholestasis, hepatocellular damage, and humoral immunoreactivity in patients with primary biliary cirrhosis (PBC).
Twenty-three consecutive patients were examined with repeated liver biopsies, laboratory tests, and ultrasonographic examinations of the hepatoduodenal ligament. The effect of treatment with ursodeoxycholic acid (UDCA) on these factors was also studied.
A correlation was found between changes in lymph node size and changes in markers of hepatocellular damage, cholestasis, and humoral immunoreactivity and also with intralobular inflammation. In the UDCA-treated patients the node size decreased slightly during 2 years of treatment, whereas it was unchanged in the control group (p = 0.0528).
Changes in the size of the lymph nodes in the hepatoduodenal ligament may reflect inflammation and cholestasis in PBC and thus be a valuable indicator in the follow-up of patients with this disease.
本研究旨在调查肝十二指肠韧带淋巴结大小的变化是否反映原发性胆汁性肝硬化(PBC)患者胆汁淤积、肝细胞损伤及体液免疫反应的生化和组织学标志物的变化。
对23例连续患者进行重复肝脏活检、实验室检查及肝十二指肠韧带超声检查。还研究了熊去氧胆酸(UDCA)治疗对这些因素的影响。
发现淋巴结大小变化与肝细胞损伤、胆汁淤积、体液免疫反应标志物变化以及小叶内炎症之间存在相关性。在接受UDCA治疗的患者中,治疗2年期间淋巴结大小略有减小,而对照组则无变化(p = 0.0528)。
肝十二指肠韧带淋巴结大小的变化可能反映PBC中的炎症和胆汁淤积,因此是该疾病患者随访中的一个有价值指标。